China expresses concern over tariffs, sanctions in US meeting
HONG KONG (Reuters) – China expressed concern over U.S. tariffs and Russia-related sanctions during a meeting of the two countries’ Economic Working Group in Washington,
Musk sends more money to back Trump, giving $44 million to super PAC
By Jason Lange and Alexandra Ulmer WASHINGTON (Reuters) – Elon Musk gave about $44 million to his pro-Donald Trump spending group during the first half
Putin says it is our affair if Russia uses North Korean troops
MOSCOW (Reuters) – President Vladimir Putin said on Friday that it was Russia’s business whether or not it decided to use North Korean troops and
Trump hates Biden’s climate law. His allies are making money from it
By Valerie Volcovici and Gram Slattery WASHINGTON (Reuters) – Donald Trump has promised to gut U.S. President Joe Biden’s climate subsidies if elected. But many
Intel to invest more than $28 billion to build two chip factories in Ohio
(Reuters) -Intel said on Friday it would invest more than $28 billion to construct two new chip factories in Licking County, Ohio, as the company
Tesla surge drives S&P 500, Nasdaq higher; IBM weighs on Dow
By Lisa Pauline Mattackal and Purvi Agarwal (Reuters) – The S&P 500 and the Nasdaq rebounded on Thursday, after Tesla’s upbeat earnings forecast lifted market
US labor market plodding along, but jobs becoming more scarce
By Lucia Mutikani WASHINGTON (Reuters) -New applications for U.S. unemployment aid unexpectedly fell last week, but the number of people collecting benefits in mid-October was
Hack at UnitedHealth’s tech unit impacted 100 million people, US health dept says
(Reuters) – The February hack at UnitedHealth’s tech unit Change affected the personal information of 100 million people, the U.S. health department’s website showed, making
Harris, Trump teams scramble for votes in North Carolina’s hurricane damaged west
By Stephanie Kelly ASHEVILLE, North Carolina (Reuters) – Republican Party leaders met in hurricane-torn North Carolina last week with a mission: figure out how to
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm